- OpenEvidence
OpenEvidence is FREE for verified U S HCPs Investors include Sequoia, Google Ventures, Kleiner Perkins, Coatue, Thrive, Conviction, ICONIQ, Greycroft, Breyer Capital, BOND, Blackstone, Mayo Clinic, and others Don′t miss our weekly email alert Stay up to date on all the new findings that matter © OpenEvidence 2025 All rights reserved
- OpenEvidence - Apps on Google Play
OpenEvidence is the world’s leading medical information platform for health care professionals, providing accurate and efficient answers at the point of care Every answer on OpenEvidence is
- OpenEvidence: The Leading AI App for Doctors - gv. com
OpenEvidence is an AI-powered application that allows physicians to ask natural language questions and get immediate answers grounded in peer-reviewed medical evidence from sources like the New England Journal of Medicine and JAMA
- OpenEvidence - journals. stfm. org
Clinicians and learners can set up an account for unlimited, free access to OE OE is accessed via an internet browser The clinical question is typed into the clearly labeled field on the middle of the screen OE then provides a scholarly style response with citations provided within the text
- OpenEvidence and the JAMA Network sign strategic content agreement
OpenEvidence is transforming how frontline healthcare providers access, evaluate, and apply the world’s medical knowledge Founded with the mission to organize and expand global medical knowledge, OpenEvidence continues to redefine evidence-based medicine in real-time
- OpenEvidence Secures $210M, Launches Free AI Agent for Clinicians
OpenEvidence, the most widely used medical search and AI application among verified U S clinicians raises $210M, launches AI Agents
- OpenEvidence AI Startup Hits $12B Valuation with $250M Raise
OpenEvidence, a three-year-old AI startup dubbed "ChatGPT for doctors," has doubled its valuation to $12 billion after raising $250 million, driven by over $100 million in annual revenue from healthcare subscriptions It offers evidence-based medical insights, amid rapid growth and regulatory challenges in AI healthcare
- ‘ChatGPT for Doctors’ Startup Doubles Valuation to $12 Billion as . . .
OpenEvidence, which operates a ChatGPT-like product for doctors to find health information from medical journals and other trusted sources, is raising $250 million in equity financing that will value the three-year-old startup at $12 billion after the investment, doubling its last private valuation from a financing announced just two months ago, according to a person involved in the deal If
|